InvestorsHub Logo
Followers 40
Posts 1780
Boards Moderated 0
Alias Born 03/23/2012

Re: None

Friday, 03/23/2018 10:25:12 PM

Friday, March 23, 2018 10:25:12 PM

Post# of 1612
HepTcell phase 1 and NasoVax phase 2 data due in Q1 2018...which ends next Friday. Earnings reported on Thursday (3/29) during premarket. Next week is setting up to be an interesting one for AltImmune.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALT News